Mike Rigby has over 30 years experience in early drug discovery, with both Merck and Pfizer. Over this period he has gained experience in a wide range of therapeutic areas in both the central nervous system and the periphery. Currently he is working at Bicycle Therapeutics in Cambridge, UK on their MT1-MMP and Nectin-4 oncology programmes
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
